Log In
BCIQ
Print this Print this
 

Ribosomal 50S subunit

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Ribosomal 50S subunit

BCIQ
Print ChartPrint this
Marketed, 1 Marketed, 9 Marketed, 5 Approved, 1 Approved, 1 Phase IV, 1 Phase III, 1 Phase III, 4 Phase II, 6 Phase II, 1 Phase II, 1 Phase II, 1 Phase I/II, 1 Phase I, 2 Preclinical, 1 Preclinical, 4
Phase of DevelopmentPreclinicalPhase IPhase I/IIPhase IIPhase IIIPhase IVApprovedMarketed
Autoimmune

-

-

-

1

-

-

-

-

Dermatology

-

-

-

-

-

-

1

5

Genitourinary

-

-

-

1

-

-

-

-

Hepatic

-

-

-

1

-

-

-

-

Infectious

4

2

1

6

4

1

1

9

Inflammation

-

-

-

-

-

-

-

1

Ophthalmic

-

-

-

-

1

-

-

-

Pulmonary

1

-

-

-

-

-

-

-




 Products Targeting Ribosomal 50S subunit
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

13

$1,894.9M

$1,609.6M

$150.8M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today